Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.835 USD | -6.84% | +0.87% | +37.76% |
05-23 | Cogent Reports Positive Cancer Combo Treatment Trial Data; Names Commercial Chief | MT |
05-23 | Cogent Biosciences, Inc. Announces the Appointment of Cole Pinnow as Chief Commercial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.76% | 804M | |
+9.10% | 115B | |
+9.60% | 105B | |
-12.94% | 22.71B | |
+3.03% | 21.83B | |
-10.86% | 18.18B | |
-41.92% | 16.52B | |
-16.24% | 16.01B | |
+1.37% | 14.14B | |
+17.86% | 10.71B |
- Stock Market
- Equities
- COGT Stock
- News Cogent Biosciences, Inc.
- Cogent Biosciences Q1 Loss Widens